BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 42 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $332,000 | -23.1% | 221,700 | -0.7% | 0.00% | – |
| Q4 2015 | $432,000 | -7.3% | 223,199 | -5.2% | 0.00% | – |
| Q3 2015 | $466,000 | -7.9% | 235,500 | -4.0% | 0.00% | – |
| Q2 2015 | $506,000 | +22.2% | 245,267 | +36.3% | 0.00% | – |
| Q1 2015 | $414,000 | +48.4% | 180,000 | +43.6% | 0.00% | – |
| Q4 2014 | $279,000 | +973.1% | 125,362 | +1053.3% | 0.00% | – |
| Q3 2014 | $26,000 | -94.3% | 10,870 | -93.3% | 0.00% | – |
| Q2 2014 | $460,000 | -55.0% | 162,063 | -3.2% | 0.00% | -100.0% |
| Q1 2014 | $1,022,000 | +8.8% | 167,338 | -25.4% | 0.00% | 0.0% |
| Q4 2013 | $939,000 | -10.6% | 224,426 | -10.8% | 0.00% | 0.0% |
| Q3 2013 | $1,050,000 | – | 251,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
| Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
| RA Capital Management | 807,855 | $1,672,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
| BVF INC/IL | 350,776 | $726,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
| Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
| Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
| KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |